[2011] FWA 8288

Download Word Document


FAIR WORK AUSTRALIA

DECISION

Fair Work Act 2009
s.739—Dispute resolution

Construction, Forestry, Mining and Energy Union
v
HWE Mining Pty Limited
(C2009/124)

VICE PRESIDENT LAWLER

MELBOURNE, 30 NOVEMBER 2011

Interpretation of agreement re drug screening.

Dispute - whether employer bound by a drug policy embodying an industrial settlement by which it agreed in relation to random on-site drug screening to move from urine testing to saliva testing when an Australian Standard for saliva testing was published - neither the industrial settlement nor the policy separately enforceable - whether policy incorporated into workplace agreement by reference and therefore enforceable as part of the workplace agreement - whether employer’s decision to vary the policy to retain a role for urine testing prevented by an application of the principle in the XPT case.

[1] This is a dispute referred to Fair Work Australia pursuant to the dispute resolution procedure in the HWE Mining Gloucester Coal Workplace Agreement 2008 1 (2008 Agreement). That referral was by way of an application under s.739 of the Workplace Relations Act 2006 as continued in force in relation to the 2008 Agreement by Schedule 19 of the Fair Work (Transitional Provisions and Consequential Amendments) Act 2009.

Background

[2] Random screening tests for drugs and alcohol has long been an established part of the safety regime at coal mines. Screening tests can be conducted on-site using a suitable testing device or samples can be collected and sent for testing off-site in a laboratory. Screening tests can be conducted on both urine and oral fluids (saliva). In this decision, unless specified otherwise, a reference to ‘testing’ is a reference to random on-site screening testing.

[3] In 2002 and 2003 the respondent (HWE) was developing fitness for work policies. HWE proposed introducing random on-site urine drug screening, being a form of screening test for which there was an Australian Standard (AS4308). A dispute arose between the applicant (CFMEU), on behalf of employees of HWE, and the HWE over the form in which drug screening tests were administered. The CFMEU was pressing for the HWE to use saliva screening tests. At that time there was no Australian Standard for on-site drug testing using saliva (oral fluids). HWE objected to the CFMEU’s demand on the basis that, on the advice it had received, the absence of adequate on-site screening test equipment and an appropriate Australian Standard for the conduct of on-site saliva screening tests meant that it was inappropriate to move from urine drug screening to saliva drug screening at that time. The dispute was resolved locally on the basis that HWE would move to saliva drug screening when an Australian Standard was published in relation to saliva drug screening. HWE’s drug and alcohol policy was amended to reflect that resolution. Thus, from late 2003 HWE had a drug testing policy entitled Drug Testing and Disciplinary Action Procedure (Drug Policy) that included the following:

[4] At the time the Drug Policy was first formulated there was no Australian Standard for on-site drug testing using saliva (oral fluids). An Australian Standard in relation to such testing was published on 1 November 2006, being AS4760. Thereafter, the CFMEU began to press HWE to honour the industrial settlement reached in 2003, comply with clause 2.2.3 of the Drug Policy and move from urine testing to saliva testing. A significant issue of concern for the CFMEU centres on the correlation between a positive test result and actual impairment for the different types of screening test. It is useful to explain this issue by reference to THC, the acronym of the psychoactive compound in cannabis. Actual impairment from THC lasts for a period after consumption that is measured in hours rather than days. On-site urine screening tests for a metabolite of THC that is present for days, even many days, after the consumption of cannabis, that is, for a period long after impairment has ceased. On the other hand, on-site saliva screening tests are targeted at smoke particulates in oral fluids and will only detect THC for a period of hours after consumption of cannabis. A positive result to an on-site saliva screening test correlates far more strongly with actual impairment when compared to on-site urine screening which will often return a positive result when there is no actual impairment. In a practical sense the dispute is ultimately about an intrusion into employees’ privacy and whether employees who consume cannabis privately while on an extended break from work should be exposed to a risk of a positive urine screening test when there is no prospect that they remain impaired when they return to work.

[5] HWE sought expert advice and, in reliance on that advice, refused to do as the CFMEU was seeking. HWE has maintained that, notwithstanding the publication of the Australian Standard AS4760, saliva testing has unacceptable inadequacies when compared to urine testing and that HWE’s overriding statutory duties in relation to occupational health and safety require it to refuse to move to saliva testing exclusively as required by the terms of clause 2.2.3 of the Drug Policy. Specifically, HWE contends that, on the current state of the on-site screening technology, saliva testing is inadequate for a number of reasons:

[6] The Drug Policy remained unchanged at the time the 2008 Agreement was made. HWE has now developed a new policy that provides for saliva testing but also retains a role for urine testing. The CFMEU objects to this new policy and contends that HWE is obliged to utilise saliva testing only. This is a dispute about whether HWE is legally obliged to move from urine testing to saliva testing as provided for in clause 2.2.3 of the Drug Policy or whether it is legally entitled to change that policy and so as to retain a role for urine testing.

Consideration

[7] The law recognises that there is an area of managerial prerogative in which an employer has the right to make decisions on how to manage their business. In Re Cram, ex parte N.S.W. Colliery Proprietors Association Limited 2 the High Court observed that “many management decisions, once viewed as the sole prerogative of management, are now correctly seen as directly affecting the relationship of employer and employee”3. That case was concerned with whether the jurisdiction of the federal tribunal (under the then legislation based on s.51(xxxv) of the Constitution) to make an award in settlement of a dispute was constitutionally limited so as to prevent any interference with managerial decisions. The High Court rejected any such limitation, observing:4

[8] Subject to express terms, there is an implied term in the contract of employment that the employee will comply with the lawful and reasonable directions of the employer 5. This is one of the principal ways in which the employer’s managerial prerogative arises from a legal perspective and forms the basis on which an employer may be said to have a right to make and vary policies that employees are required to observe.

[9] As was observed by the Full Bench in Woolworths v Brown 6:

[10] However, managerial prerogative in relation to employees (including the employer’s right to make and vary policies that employees are required to observe) is subject to legal constraints. It may be constrained by statute or the terms of an award. It may also be constrained by the terms of a contract of employment or a statutory agreement that the employer chooses to make. For example, an enterprise agreement might provide that all work must be carried out in accordance with a roster pattern specified in the agreement. In that example, unless the agreement also confers a right on the employer to vary the roster pattern, the employer has bound itself not to require employees to work a different roster pattern. In particular, an employer can bind itself in a statutory collective agreement not to change a policy or policies without, for example, the agreement of a relevant union or a majority of employees.

[11] If an employer’s exercise of managerial prerogative is not prevented by statute, an award, a statutory agreement or the contract of employment, the basis for a tribunal such as Fair Work Australia, acting as an arbitrator of a dispute, interfering with what would otherwise be a lawful exercise of managerial prerogative (such as the making or varying of a policy which employees are required to observe) was laid down Australian Federated Union of Locomotive Enginemen v State Rail Authority of New South Wales 7 (XPT case):

[12] I proceed on the basis that an exercise of managerial prerogative will not be unreasonable in this sense if a reasonable person in the position of the employer, could have made the decision in question.

The issues

[13] It is common ground that the industrial settlement that resulted in clause 2.2.3 being added to the Drug Policy, like many industrial settlements, was not a legally enforceable agreement. It is not suggested that the Drug Policy is itself directly legally enforceable against HWE: the Drug Policy itself is not a legally binding agreement. The real issue is whether the 2008 Agreement has the effect of rendering clause 2.2.3 enforceable against HWE because it incorporated the Drug Policy by reference such that HWE must comply with clause 2.2.3 and move to saliva testing only and is prevented from adopting its new policy. If not, the only basis on which Fair Work Australia acting as private arbitrator can properly determine that HWE not vary the Drug Policy to remove clause 2.2.3 and or require it to move to saliva testing is by an application of the principle in the XPT case. I note that my role is to decide those issues. My role is not to decide whether an employer in HWE’s position could reasonably move to saliva testing alone or what I would do if I was in HWE’s position.

Was the Drug Policy incorporated by reference into the 2008 Agreement such that clause 2.2.3 is enforceable against HWE as part of the 2008 Agreement?

[14] The 2008 Agreement deals generally with policies in only one clause:

[15] It may be noted that the predecessor collective agreement made in 2006 contains a relevantly identical clause.

[16] Other clauses in the 2008 Agreement that refer to “policy” or “policies” are:

[17] Clause 6(h), by its terms, imposes an obligation on employees to comply with “all Company policies, procedures and requirements”. It does not expressly impose any obligation on HWE in relation to policies. The CFMEU relies upon the decision of the majority of the Full Court of the Federal Court in Riverwood International Australia Pty Ltd v McCormick 8 (Riverwood) in contending that clause 6(h) should be construed as imposing an obligation on HWE to comply with clause 2.2.3 of the Drug Policy.

[18] In Yousif v Commonwealth Bank of Australia 9 (Yousif) the Full Court of the Federal Court distinguished Riverwood and emphasised that it was a case that turned on its own particular facts. In Yousif the contract of employment contained a clause headed “Policies and Procedures” that provided: “You [the employee] are required to comply with all Bank policies and procedures existing from time to time.” The Full Court observed:

[19] The Full Court agreed with the trial judge that a disclaimer in the manual against its incorporation into the contract of employment was determinative against incorporation of the manual by reference in that case 10.

[20] Relevant principles of construction in this context were usefully summarised by Tracey J in Carr v Blade Repairs Australia Pty Ltd (No 2) 11:

[21] This practical approach accords with the established approach to the construction of industrial agreements laid down in cases such as Kucks v CSR Ltd 12 and Short v FW Hercus Pty Ltd13. Adopting that practical approach I am unable to construe the language of clause 6(h) or the rest of the 2008 Agreement so as to conclude that HWE is prevented by the terms of the 2008 Agreement from making new policies or varying existing policies - including the drug policy. In particular, I cannot find that the reference to “the Company’s performance management policy, as it exists from time to time” in clause 6(c) provides a basis for concluding that, objectively determined, the parties intended that only the performance management policy could be varied and that all other polices would remain unchanged.

[22] There are significant points of distinction between the 2008 Agreement and its context and the contract of employment in Riverwood and its context. In Riverwood all the relevant policies were contained in a single human resources manual and were almost entirely concerned with conferring benefits on employees. In this case, HWE clearly has a number of separate policies and there is no evidence that allows me to conclude that those policies almost entirely confer benefits on employees. The Drug Policy is manifestly a policy that is primarily for the benefit of HWE and securing its compliance with the onerous statutory occupational health and safety obligations to which it is subject and which are amenable to change. This is a fundamental point of distinction when a practical approach to construction is adopted. Moreover, clause 6(h) is not confined to policies but instead extends to “policies, procedures and requirements”. The term “requirements” significantly extends the scope of clause 6(h) and, read as whole, clause 6(h) may properly be seen as an express embodiment of the implied term that employees comply with all lawful and reasonable directions - a term that is manifestly for the benefit of the employer. In Riverwood the employer was not seeking to vary its policy. Rather, the issue was simply whether the policy in question was enforceable against the employer. Here, the real issue is whether clause 2.2.3 of the Drug Policy is enforceable and fixed such that HWE does not have the right to vary the Drug Policy to remove clause 2.2.3 and to introduce a new drug and alcohol policy of the sort that it proposes.

[23] I recognise that the fact of the industrial settlement that led to clause 2.2.3 being included in the Drug Policy may properly be seen as part, albeit a small part, of the historical context in which the 2008 Agreement as a whole was made. However, I am not persuaded that that factor leads to a different outcome in the present case given the breadth of the obligation in clause 6(h), the purposes specified in paragraphs 3(a) and (c) and the fact that the ownership of HWE changed in 2005.

[24] I find that on the proper construction of the 2008 Agreement clause 6(h) does not incorporate all “policies, procedures and requirements” by reference such that the Drug Policy is enforceable against HWE. On its proper construction, the 2008 Agreement does not limit HWE’s managerial prerogative to vary it policies, including the Drug Policy.

Challenge to managerial prerogative on the basis of the principle in the XPT case

[25] The issue now becomes whether the principle in the XPT case provides a basis for interfering with HWE’s exercise of managerial prerogative to vary the Drug Policy. The CFMEU and HWE each called evidence from an impressive expert witness. While there were some differences of opinion between those two experts, it is unnecessary for me to resolve them because even if I confine my consideration only to the matters accepted by Dr Gerostamoulos, the expert called by the CFMEU, I am compelled to the conclusion that the present application must be dismissed and HWE’s position vindicated. Dr Gerostamoulos accepted the following:

[26] In the light of these matters, HWE’s conclusion that, notwithstanding the industrial settlement embodied in clause 2.2.3 of the Drug Policy, it should not move to saliva testing is eminently reasonable. Impairment by drugs or alcohol is an important safety issue at coal mines. The nature of the mining process and the plant and equipment used in mining is such that employees who are impaired by drugs or alcohol present a substantial safety risk to themselves and others that must be controlled. There are very onerous statutory occupational health and safety obligations imposed on employers in New South Wales. The key issue is impairment: it is the employee who is impaired by drugs or alcohol who presents the risk. The use of on-site screening rather than laboratory screening is well justified by HWE’s concern that the delay between the taking of a sample and obtaining the results of a laboratory test may lead to employees who are actually impaired working on dangerous equipment when that would not occur if an effective on-site screening test had been used. While it may be so that the primary purpose of random screening for drugs and alcohol is deterrence and that saliva screening would still have a deterrent effect, it is reasonably open to an employer subject to the onerous statutory occupational health and safety regime that applies to HWE to be concerned to ensure that its drug screening is as reliable as reasonably possible in detecting impaired employees. If on-site screening is to be used, the matters accepted by Dr Gerostamoulos provide compelling rational reasons for regarding saliva testing as less effective than urine testing, notwithstanding there is now an Australian Standard for saliva testing. The materially higher incidence of false negatives with on-site saliva screening and the greater scope for defeating existing on-site saliva screening tests are particularly significant.

[27] The CFMEU placed a particular reliance on the decision of Senior Deputy President Hamberger in Shell Refining (Australia) Pty Ltd v Construction, Forestry, Mining and Energy Union 28 (Shell). I respectfully agree with that decision and his Honour’s approach given the position adopted by the parties and the evidence before him. In particular I agree that considerations relating to employee privacy are an important factor.

[28] However, I have a different body of evidence before me and an employer who has adopted a position different to the employer in Shell. In Shell the employer was only ever concerned with the conduct of drug screening tests where samples were to be analysed in a laboratory: it was not seeking to introduce screening using an on-site screening device where the result is available immediately after the test is administered. The expert evidence before Hamberger SDP and before me indicated that laboratory testing of saliva is essentially as reliable as laboratory testing of urine in detecting relevant drugs - it is the currently available on-site screening devices for saliva that are materially less reliable. It was in that context that the considerations relating to employee privacy became determinative.

[29] I proceed on the basis that an exercise of managerial prerogative that is contrary to an industrial settlement could, in appropriate circumstances, on that account alone be found to be unjust or unreasonable within the meaning of the principle of the XPT case. However, on the evidence before me I cannot find that HWE’s refusal to move to saliva testing in accordance with the industrial settlement embodied in clause 2.2.3 of the Drug Policy, and to instead change that policy to provide for saliva testing but with a continuing role for urine testing, is unjust or unreasonable such that the principle in the XPT case provides a basis interfering with HWE’s decision to vary the Drug Policy in the way that it proposes. I would have reached a different conclusion if the evidence indicated that the reliability ‘gap’ between on-site urine screening and on-site saliva screening was relatively small.

[30] For these reasons, I must determine the dispute in favour of HWE and endorse its right to vary the Drug Policy in the manner it proposes and direct employees to comply with that policy as varied.

VICE PRESIDENT

Appearances:

S Crawshaw, Senior Counsel and J Gray for the Construction, Forestry, Mining and Energy Union.

H Dixon of Senior Counsel and B Weir for HWE Mining Pty Ltd.

Hearing details:

2009.
Sydney:
September 23 (telephone hearing).
November 19 (telephone hearing).

2010.
Sydney:
January 18 (telephone hearing).
May 24, 25.
June 29.

 1   AC314474

 2   (1987) 163 CLR 117

 3   Ibid at p. 135

 4   Ibid at pp. 136-7

 5   Adami v Maison de Luxe Ltd (1924) 35 CLR 143 at p. 151; R v Darling Island Stevedoring and Lighterage Co. Limited; Ex parte Halliday & Sullivan (1938) 60 CLR 601 at p. 621; Lister v Romford Ice & Cold Storage Co Ltd [1957] AC 555 at p. 594; Macken’s Law of Employment (7th ed), para [5.790]

 6   (2005) 145 IR 285

 7   (1984) 295 CAR 188

 8   (2000) 177 ALR 193 (North and Mansfield JJ; Lindgren JJ dissenting)

 9   (2010) 193 IR 212 (Kenny, Tracey and Jagot JJ)

 10   [2010] FCAFC 8 at [94] - [96]

 11   (2010) 197 IR 307

 12   (1996) 66 IR 182

 13   (1993) 46 IR 128

 14   PN265, PN349

15 PN314

16 PN412

17 PN317

18 PN264

19 PN295-296

20 PN267

21 PN300

22 PN439-441; PN445

23 Exhibit 1, para 5; Transcript at PN298

24 PN292

25 PN268, PN273

26 PN382

27 PN383

 28   [2008] AIRC 510

Printed by authority of the Commonwealth Government Printer

<Price code C, PR517336>